Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06592274
What this trial is testing

HB0017 in Psoriasis Patients

Who this might be right for
Psoriasis (PsO)
Huabo Biopharm Co., Ltd. 200
Early research (Phase 1)Ended earlyNCT02199886
What this trial is testing

Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection

Who this might be right for
Lung Neoplasms
Boehringer Ingelheim 6
Testing effectiveness (Phase 2)Study completedNCT00140387
What this trial is testing

Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®)

Who this might be right for
Prostate Cancer
Cell Genesys 20
Early research (Phase 1)Study completedNCT02250157
What this trial is testing

A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumor
Athenex, Inc. 35
Early research (Phase 1)Study completedNCT00857311
What this trial is testing

MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 17
Testing effectiveness (Phase 2)Looking for participantsNCT07557446
What this trial is testing

A Dose REgimen-Finding Study of AGA2115 in Chinese Patients With Osteogenesis ImpeRfecta (EIR)

Who this might be right for
Osteogenesis Imperfecta (OI)
Angitia Biopharmaceuticals Guangzhou Limited 48
Testing effectiveness (Phase 2)Study completedNCT00299975
What this trial is testing

A Dose Determination Study of Chinese Herbal Medicine for Functional Constipation

Who this might be right for
Constipation
Hong Kong Baptist University 97
Post-approval studies (Phase 4)Ended earlyNCT03231228
What this trial is testing

Safety of 1 g and 2 g of Cefazolin in Pediatric Subjects

Who this might be right for
Postoperative Infection
B. Braun Medical Inc. 61
Not applicableStudy completedNCT00336557
What this trial is testing

Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 1,230
Early research (Phase 1)Study completedNCT04585321
What this trial is testing

Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day

Who this might be right for
Bioequivalence Study
Fidia Farmaceutici s.p.a. 52
Early research (Phase 1)Study completedNCT05561673
What this trial is testing

A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Who this might be right for
Hepatitis B
GlaxoSmithKline 122
Testing effectiveness (Phase 2)Study completedNCT06680466
What this trial is testing

A Phase Ⅱ Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain After Abdominal Surgery

Who this might be right for
Pain
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. 179
Not applicableStudy completedNCT03931239
What this trial is testing

The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Vabiotech 222
Large-scale testing (Phase 3)Study completedNCT00793377
What this trial is testing

Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer

Who this might be right for
Primary Breast Cancer
GBG Forschungs GmbH 913
Post-approval studies (Phase 4)Study completedNCT00928070
What this trial is testing

Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder

Who this might be right for
Overactive Bladder
Pfizer 566
Large-scale testing (Phase 3)Study completedNCT01819727
What this trial is testing

An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165

Who this might be right for
Phenylketonuria
BioMarin Pharmaceutical 261
Post-approval studies (Phase 4)Study completedNCT00334412
What this trial is testing

COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis

Who this might be right for
Invasive Aspergillosis
Gilead Sciences 30
Testing effectiveness (Phase 2)Study completedNCT00700635
What this trial is testing

Dose Comparison Study of Menactra® in US Children

Who this might be right for
MeningitisMeningococcal InfectionNeisseria Meningitidis
Sanofi Pasteur, a Sanofi Company 333
Testing effectiveness (Phase 2)Study completedNCT00434512
What this trial is testing

Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers

Who this might be right for
AIDSHIV Infections
GlaxoSmithKline 180
Post-approval studies (Phase 4)Study completedNCT01000324
What this trial is testing

Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult

Who this might be right for
Hepatitis AHepatitis B
GlaxoSmithKline 44
Next Page